Evidence map›Paper›PMID 42941263›Full record

ReviewMetabolites2026

Lactate-Driven Biphasic Reprogramming of Macrophage Immune Responses.

Qingshuang Guo, Pan Ren, Lanqi He, Jiaying Gao, Ruiqi Lu, Yitian Wang, Zhiheng Zhang, Xiaohui Han, Xi Zhang, Chao Fang

Abstract readReview
In one paragraph

Review in Metabolites, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Qingshuang GuoSchool of Medicine, Northwest University, Xi'an 710069, China.
Pan RenDepartment of Burns, Plastic and Wound Repair Surgery, the Second Affiliated Hospital, Xi'an Jiaotong University, Xi'an 710004, China.
Lanqi HeDepartment of Plastic and Reconstructive Surgery, Xijing Hospital, Fourth Military Medical University, Xi'an 710032, China.
Jiaying GaoDepartment of Plastic and Reconstructive Surgery, Xijing Hospital, Fourth Military Medical University, Xi'an 710032, China.
Ruiqi LuSchool of Medicine, Northwest University, Xi'an 710069, China.
Yitian WangDepartment of Pharmacology, School of Pharmacy, Fourth Military Medical University, Xi'an 710032, China.
Zhiheng ZhangDepartment of Pharmacology, School of Pharmacy, Fourth Military Medical University, Xi'an 710032, China.ORCID 0009-0006-3514-2502
Xiaohui HanSchool of Medicine, Northwest University, Xi'an 710069, China.
Xi ZhangDepartment of Plastic and Reconstructive Surgery, Xijing Hospital, Fourth Military Medical University, Xi'an 710032, China.
Chao FangDepartment of Pharmacology, School of Pharmacy, Fourth Military Medical University, Xi'an 710032, China.ORCID 0000-0003-1011-2113

Funding

National Natural Science Foundation of China 81903671Natural Science Basic Research Program of Shaanxi Province 2025JC-QYCX-072Natural Science Basic Research Program of Shaanxi Province 2025JC-YBQN-1037Second Affiliated Hospital of Xi'an Jiaotong University YJ(YB)202508
6 · The paper itself

Abstract

Lactate is a metabolic substrate, an extracellular signaling molecule, and a precursor for protein lactylation, with diverse effects on macrophage immunity. Evidence from infection, tissue injury, efferocytosis, and cancer indicates that lactate-associated pathways can amplify inflammation, support resolution and tissue repair, or sustain immune suppression. These outcomes depend on the timing, cellular source and compartment, chemical formulation and pH, transport and receptor engagement, and the chemistry and targets of lactylation. In this narrative review, we critically synthesize the biochemical foundations of lactate metabolism and lactyl-group donation and examine the mechanisms underlying these distinct macrophage responses. We distinguish model-specific biphasic responses from a universal sequence of early inflammation followed by resolution, and separate reparative programs from impaired antimicrobial or antitumor immunity. We also evaluate evidence for histone and non-histone lactylation, emphasizing the limits of metabolic perturbations and chromatin associations for establishing site-specific causality. This framework identifies experimental variables that should be controlled and supports context-selective investigation of lactate-related therapeutic targets in inflammatory diseases and cancer.

Indexed as

immune regulationimmunometabolismlactatelactylationmacrophage plasticity

Identifiers

PMID42941263
PMCPMC13706687

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.